N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma
- PMID: 16510586
- DOI: 10.1158/0008-5472.CAN-05-2198
N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma
Abstract
Medulloblastoma is a malignant brain tumor that arises in the cerebellum in children, presumably from granule neuron precursors (GNP). Advances in patient treatment have been hindered by a paucity of animal models that accurately reflect the molecular pathogenesis of human tumors. Aberrant activation of the Sonic hedgehog (Shh) and insulin-like growth factor (IGF) pathways is associated with human medulloblastomas. Both pathways are essential regulators of GNP proliferation during cerebellar development. In cultured GNPs, IGF signaling stabilizes the oncogenic transcription factor N-myc by inhibiting glycogen synthase kinase 3beta-dependent phosphorylation and consequent degradation of N-myc. However, determinants of Shh and IGF tumorigenicity in vivo remain unknown. Here we report a high frequency of medulloblastoma formation in mice following postnatal overexpression of Shh in cooperation with N-myc. Overexpression of N-myc, alone or in combination with IGF signaling mediators or with the Shh target Gli1, did not cause tumors. Thus, Shh has transforming functions in addition to induction of N-myc and Gli1. This tumor model will be useful for testing novel medulloblastoma therapies and providing insight into mechanisms of hedgehog-mediated transformation.
Similar articles
-
Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice.Cancer Res. 2007 Jun 1;67(11):5179-85. doi: 10.1158/0008-5472.CAN-06-4177. Cancer Res. 2007. PMID: 17545597
-
Sequential activation of Snail1 and N-Myc modulates sonic hedgehog-induced transformation of neural cells.Cancer Res. 2011 Aug 1;71(15):5336-45. doi: 10.1158/0008-5472.CAN-10-2633. Epub 2011 Jun 6. Cancer Res. 2011. PMID: 21646478 Free PMC article.
-
Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells.Cancer Res. 2010 Jul 1;70(13):5618-27. doi: 10.1158/0008-5472.CAN-09-3740. Epub 2010 Jun 1. Cancer Res. 2010. PMID: 20516124 Free PMC article.
-
Neural precursor cycling at sonic speed: N-Myc pedals, GSK-3 brakes.Cell Cycle. 2006 Jan;5(1):47-52. doi: 10.4161/cc.5.1.2292. Epub 2006 Jan 1. Cell Cycle. 2006. PMID: 16322694 Review.
-
Modeling medulloblastoma with genetically engineered mice.Neurosurg Focus. 2005 Nov 15;19(5):E7. doi: 10.3171/foc.2005.19.5.8. Neurosurg Focus. 2005. PMID: 16398471 Review.
Cited by
-
Medulloblastoma stem cells.J Clin Oncol. 2008 Jun 10;26(17):2821-7. doi: 10.1200/JCO.2007.15.2264. J Clin Oncol. 2008. PMID: 18539960 Free PMC article. Review.
-
WNT3 inhibits cerebellar granule neuron progenitor proliferation and medulloblastoma formation via MAPK activation.PLoS One. 2013 Nov 26;8(11):e81769. doi: 10.1371/journal.pone.0081769. eCollection 2013. PLoS One. 2013. PMID: 24303070 Free PMC article.
-
The molecular genetics of medulloblastoma: an assessment of new therapeutic targets.Neurosurg Rev. 2008 Oct;31(4):359-68; discussion 368-9. doi: 10.1007/s10143-008-0146-4. Epub 2008 Jun 12. Neurosurg Rev. 2008. PMID: 18548301 Review.
-
Modeling pediatric medulloblastoma.Brain Pathol. 2020 May;30(3):703-712. doi: 10.1111/bpa.12803. Epub 2019 Dec 17. Brain Pathol. 2020. PMID: 31788908 Free PMC article. Review.
-
The prenatal origins of cancer.Nat Rev Cancer. 2014 Apr;14(4):277-89. doi: 10.1038/nrc3679. Epub 2014 Mar 6. Nat Rev Cancer. 2014. PMID: 24599217 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases